BIO Deutschland gathered important data about the German biotech sector in a survey it conducted among companies at the start of the year. The key performance indicators were published in the EY report “Im Schatten von Leuchttürmen” [In the Shadow of Lighthouse Companies] and presented at a press conference held in Frankfurt.
Germany’s national forum for biotechnology was held this year from 26 to 27 April in Leipzig. The seventh edition of the leading networking event for the German biotech industry drew over 830 registered participants from across Germany and Europe to Saxony’s largest city.
BIO Deutschland was an active participant in the Federal Government’s Pharma Dialogue, as you have probably gathered from previous reports on the subject. This dialogue, which began in autumn of 2014 and consisted of four rounds of meetings, got all stakeholders in Germany’s pharmaceutical value chain together at one table. The Pharma Dialogue’s final report was presented on 12 April at its concluding event in Berlin.
BIO Deutschland, together with the SME Alliance, discussed the digital agenda of the Federal Government with State Secretary Klaus Vitt of the Federal Ministry of the Interior (BMI).
On the occasion of Lithuanian President Dalia Grybauskaitė’s visit to Germany, the ambassador of the Republic of Lithuania organised a life sciences symposium in Berlin.